Thyroxine replacement during super-ovulation for in vitro fertilization: a potential gap in management?
To access this article, please choose from the options below
B.G.A.S. has nothing to disclose. D.Y. has nothing to disclose. S.R.T. has nothing to disclose.
PII: S0015-0282(09)04143-0
doi:10.1016/j.fertnstert.2009.11.051
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

